A first Proof-of-concept phase II study of nitazoxanide in NASH patients with advanced fibrosis.

Trial Profile

A first Proof-of-concept phase II study of nitazoxanide in NASH patients with advanced fibrosis.

Planning
Phase of Trial: Phase II

Latest Information Update: 25 Sep 2017

At a glance

  • Drugs Nitazoxanide (Primary)
  • Indications Hepatic fibrosis; Non-alcoholic steatohepatitis
  • Focus Therapeutic Use
  • Most Recent Events

    • 25 Sep 2017 According to a GENFIT media release, the Company plans to submit to the FDA an application for authorization to launch this trial before the end of 2017.
    • 28 Apr 2017 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top